SciVision Biotech Aug revenue falls to NT$66.4M vs NT$85.9M
SciVision Biotech reported August revenue of NT$66,363,000 versus NT$85,888,000 in 2025. Jan-Aug revenue was NT$557,917,000 versus NT$574,895,000 in 2025, Taiwan Stock Exchange data.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.